[{"_id":"551f897531cae9239deb1596","会社名":"(株)リニカル【2183】","証券コード":"2183","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月12日","決算月数":"12か月","売上高":"3,721百万円","営業利益":"706百万円","経常利益":"703百万円","当期利益":"449百万円","EPS（一株当たり利益）":"39.42円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"162.52円","総資産":"2,836百万円","自己資本":"1,851百万円","資本金":"214百万円","有利子負債":"397百万円","自己資本比率":"65.3%","ROA（総資産利益率）":"16.39%","ROE（自己資本利益率）":"26.14%","総資産経常利益率":"25.67%","__v":0,"日付":"2015-04-04T06:49:25.471Z"},{"_id":"551f897531cae9239deb1597","会社名":"(株)リニカル【2183】","証券コード":"2183","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月10日","決算月数":"12か月","売上高":"3,599百万円","営業利益":"1,003百万円","経常利益":"998百万円","当期利益":"616百万円","EPS（一株当たり利益）":"54.13円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"139.05円","総資産":"2,642百万円","自己資本":"1,584百万円","資本金":"214百万円","有利子負債":"427百万円","自己資本比率":"60.0%","ROA（総資産利益率）":"25.69%","ROE（自己資本利益率）":"46.23%","総資産経常利益率":"41.62%","__v":0,"日付":"2015-04-04T06:49:25.471Z"},{"_id":"551f897531cae9239deb1598","会社名":"(株)リニカル【2183】","証券コード":"2183","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月11日","決算月数":"12か月","売上高":"3,110百万円","営業利益":"728百万円","経常利益":"723百万円","当期利益":"424百万円","EPS（一株当たり利益）":"37.23円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"94.93円","総資産":"2,154百万円","自己資本":"1,081百万円","資本金":"214百万円","有利子負債":"457百万円","自己資本比率":"50.2%","ROA（総資産利益率）":"22.83%","ROE（自己資本利益率）":"45.47%","総資産経常利益率":"38.92%","__v":0,"日付":"2015-04-04T06:49:25.472Z"}]